Evidence map›Paper›PMID 38886857›Full record

ArticleResearch involvement and engagement2024

Engaging a community to focus on upper limb function in people with multiple sclerosis: the ThinkHand campaign case study.

Alison Thomson, Rachel Horne, Christine Chapman, Trishna Bharadia, Patrick Burke, Elizabeth Colwell, Mark Harrington, Bonnie Boskovic, Andrea Stennett, David Baker and 2 more

Abstract readLetter
In one paragraph

Article in Research involvement and engagement, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alison ThomsonCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK. a.thomson@qmul.ac.uk.
Rachel HornePatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Christine ChapmanPatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Trishna BharadiaPatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Patrick BurkePatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Elizabeth ColwellPatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Mark HarringtonPatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Bonnie BoskovicPatient Author, Barts MS Advisory Group, Queen Mary University of London, London, UK.
Andrea StennettCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
David BakerThe Blizard Institute, Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK.
Gavin GiovannoniCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Klaus SchmiererThe Blizard Institute, Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London, London, UK.

Funding

Morris-Saady Charitable Trust NCT04695080National Institute of Health and Care Research 17/145/09Roche NCT04035005
6 · The paper itself

Abstract

backgroundSolving complex research challenges requires innovative thinking and alternative approaches to traditional methods. One such example is the problem of arm and hand, or upper limb function in multiple sclerosis (MS), a neurological condition affecting approximately 2.9 million people worldwide and more than 150,000 in the United Kingdom. Historically, clinical trials and research have focused on mobility and walking ability. This excludes a large number of patients who are wheelchair users, limiting their quality of life and restricting access to possibly helpful medications. To address this issue, the ThinkHand campaign was launched in 2016, aiming to raise awareness about the importance of upper limb function in MS and develop alternative ways to measure, record, and account for hand and arm function changes. MAIN BODY: The campaign utilised innovative strategies at scientific conferences and online surveys to engage people affected by MS, healthcare professionals, charities, and researchers in discussing the importance of preserving upper limb function. Through co-design and interdisciplinary collaboration, the campaign developed new tools like the low-cost cardboard version of the Nine-Hole Peg Test, facilitating remote monitoring of hand function. Additionally, the campaign co-created the "Under & Over" rehabilitation tool, allowing individuals with advanced MS to participate in a remote rehabilitation program.The impact of the ThinkHand campaign has been significant, helping to shift the focus of both academic and industry-supported trials, including the O'HAND and ChariotMS trials, both using upper limb function as their primary end point. The campaign's patient-centred approach highlighted the importance of recognising patients' perspectives in research and challenged established assumptions and practices. It demonstrated the effectiveness of interdisciplinary collaboration, systems thinking, and co-creation with stakeholders in tackling complex problems.

conclusionThe ThinkHand campaign provides valuable insights for health research practices. By involving patients at all stages, researchers can gain a deeper understanding of the impact of disease on their lives, identify gaps and focus research on their needs. Experimentation and iteration can lead to innovative solutions, and openness to unconventional methods can drive widespread change. The ThinkHand campaign exemplifies the potential of patient-centred approaches to address complex research challenges and revolutionise the field of MS research and management. Embracing such approaches will contribute to more inclusive and impactful research in the future.

Indexed as

Clinical trialsCo-creationDesignMultiple SclerosisPatient-centredPatient public involvementPublic engagement

Identifiers

PMID38886857
PMCPMC11184845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.